Health - and all issues that accompany it - is viewed quite differently from the provincial perspective. To combat a persistent cough, a person from the big city would most likely reach for a pharmacy grade Guaifenesin; a person from the far provinces however, would instead opt for a herbal preparation proven effective through generations of use.
Following this idea, one may begin to identify the many aspects that affect the chemical vs concoction decision-making process in the primary health care, such as accessibility, availability, affordability and acceptability of the cure.
Those aspects however just barely scratch the surface. Should a cheaper variant of the pharmacy cure be developed for the provinces or should a pharmacy drug be developed based on the provincial herbal mixtures? The rise of these questions merits the conduct of research for the development of solutions applicable for both the city and the provincial scene.
Recently, agencies behind the development of the Regional Unified Health Research Agenda (RUHRA) began their provincial consultations to identify the health issues, needs, and concerns of provinces in region IX for 2017 to 2022.
